Sonuç Sayfası 2 için Endüstri: İlaç Üreticileri-Genel Borsası - Teklifler ve Fiyatlar
Fiyatlar, Piyasa Değerleri, PE ve EPS oranları ile tüm Hisse ve Net Varlıkların Listesi
Tüm ülkeler
- {{country.name}}
- Tüm ülkeler
- Amerika Birleşik Devletleri (50)
- Arjantin (13)
- Avustralya (1)
- Avusturya (13)
- Brezilya (14)
- Kanada (2)
- Şili (4)
- Çin (22)
- Finlandiya (2)
- Fransa (3)
- Almanya (58)
- Hong Kong (4)
- Macaristan (1)
- Hindistan (20)
- Endonezya (1)
- İtalya (5)
- Japonya (9)
- Meksika (14)
- Singapur (1)
- Güney Kore (3)
- ispanya (1)
- İsveç (3)
- İsviçre (6)
- Tayvan (1)
- Türkiye (1)
- Birleşik Krallık (20)
Tüm borsalar
- {{item.name}}
- Tüm borsalar
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
Tüm sektörler
- {{item.name}}
- Tüm sektörler
- Sağlık Hizmetleri (279)
İlaç Üreticileri-Genel (279)
- {{item.name}}
- Tüm Sektörler
- Tarımsal Girdiler (323)
- Yapı Malzemeleri (471)
- Kimyasallar (605)
- Özel Kimyasallar (1353)
- Kereste ve Odun Üretimi (160)
- Kağıt ve Kağıt Ürünleri (269)
- Alüminyum (141)
- Bakır (216)
- Diğer Endüstriyel Metaller ve Madencilik (2765)
- Altın (1700)
- Gümüş (84)
- Diğer Değerli Metaller ve Madencilik (660)
- Kok Kömürü (71)
- Çelik (744)
- Otomobil ve Kamyon Bayileri (212)
- Otomobil Üreticileri (388)
- Otomobil Parçaları (1166)
- Rekreasyonel Taşıtlar (85)
- Döşemeler, Fikstürler ve Ev Eşyaları (507)
- Konut İnşaatı (214)
- Tekstil Üretimi (520)
- Giysi Üretimi (444)
- Ayakkabı ve Aksesuar (208)
- Ambalajlama ve Konteynerler (481)
- Kişisel Hizmetler (140)
- Restoranlar (539)
- Perakende Giyim (289)
- Büyük Mağazalar (276)
- Perakende Ev İyileştirme (106)
- Lüks Mallar (260)
- İnternet Üzerinden Perakende (408)
- Özel Perakende (547)
- Şans Oyunları (205)
- Dinlence (411)
- Konaklama (321)
- Tatil Yerleri ve Casino'lar (188)
- Seyahat Hizmetleri (192)
- Varlık Yönetimi (1966)
- Bankalar-Çeşitli (308)
- Bankalar-Bölgesel (2297)
- İpotek Finansı (171)
- Sermaye Piyasaları (888)
- Finansal Veriler ve Borsalar (151)
- Sigorta-Hayat (260)
- Sigorta-Mülk ve Hasar (270)
- Sigorta-Reasürans (74)
- Sigorta-Özel (72)
- Sigorta Komisyoncuları (67)
- Sigorta-Çeşitli (306)
- Paravan Şirketler (1820)
- Finansal Holdingler (100)
- Kredi Hizmetleri (660)
- Gayrimenkul-Geliştirme (966)
- Gayrimenkul Hizmetleri (1145)
- Gayrimenkul-Çeşitli (316)
- REIT-Sağlık Hizmetleri Tesisleri (64)
- REIT-Otel ve Motel (86)
- REIT-Endüstriyel (141)
- REIT-Ofis (169)
- REIT-Konut (108)
- REIT-Perakende (230)
- REIT-İpotek (130)
- REIT-Özel (83)
- REIT-Çeşitli (332)
- İçecekler-Bira Üreticileri (162)
- İçecekler-Şarap ve İçki İmalathaneleri (242)
- İçecekler-Alkolsüz (217)
- Şekerlemeciler (170)
- Çiftlik Ürünleri (610)
- Ev Eşyaları ve Kişisel Ürünler (523)
- Ambalajlı Gıdalar (1270)
- Eğitim ve Öğretim Hizmetleri (305)
- İndirim Mağazaları (97)
- Yemek Dağıtım (210)
- Marketler (233)
- Tütün (105)
- Biyoteknoloji (2611)
- İlaç Üreticileri-Genel (279)
- İlaç Üreticileri-Özel ve Genel (1705)
- Sağlık Hizmeti Planları (57)
- Tıbbi Bakım Tesisleri (553)
- Farmasötik Perakendeciler (155)
- Sağlık Bilgileri Hizmetleri (419)
- Tıbbi Cihazlar (913)
- Tıbbi Ekipmanlar ve Malzemeler (501)
- Teşhis ve Araştırma (427)
- Medikal Ürün Dağıtımı (138)
- Kamu Hizmetleri-Bağımsız Güç Üreticileri (170)
- Kamu Hizmetleri-Yenilenebilir (561)
- Kamu Hizmetleri-Su Tedariki (173)
- Kamu Hizmetleri-Elektrik Tedariki (468)
- Kamu Hizmetleri-Doğalgaz Tedariki (205)
- Kamu Hizmetleri-Çeşitli (214)
- Telekomünikasyon Hizmetleri (910)
- Reklam Ajansları (508)
- Yayımcılık (259)
- Yayıncılık (213)
- Eğlence (679)
- İnternet İçerikleri ve Bilgiler (530)
- Elektronik Oyunlar ve Multimedya (484)
- Petrol ve Gaz Sondajlama (80)
- Petrol ve Gaz Arama ve Üretimi (1185)
- Petrol ve Gaz - Entegre (246)
- Petrol ve Gaz - Orta Akım (230)
- Petrol ve Gaz Rafinesi ve Pazarlaması (278)
- Petrol ve Gaz Ekipmanları ve Hizmetleri (480)
- Termal Kömür (229)
- Uranyum (140)
- Hava-uzay ve Savunma (560)
- Özel İş Hizmetleri (640)
- Danışmanlık Hizmetleri (195)
- Kiralama ve Leasing Hizmetleri (219)
- Güvenlik ve Koruma Hizmetleri (267)
- İstihdam ve İşe Alım Hizmetleri (252)
- Holdingler (723)
- Mühendislik ve İnşaat (1492)
- Altyapı Operasyonları (156)
- Yapı Ürünleri ve Ekipmanları (513)
- Tarım ve Ağır İş Makineleri (376)
- Endüstriyel Dağıtım (235)
- İş Ekipmanları ve Malzemeleri (142)
- Özel Endüstriyel Makineler (1720)
- Metal Üretimi (393)
- Kirlilik ve Arıtma Kontrolleri (265)
- Araçlar ve Aksesuarlar (240)
- Elektrikli Ekipmanlar ve Parçalar (897)
- Havalimanları ve Hava Hizmetleri (135)
- Hava Yolları (229)
- Demir Yolları (260)
- Deniz Taşımacılığı (505)
- Kamyon Taşımacılığı (99)
- Entegre Nakliye ve Lojistik (388)
- Atık Yönetimi (354)
- Bilişim Teknolojileri Hizmetleri (1178)
- Yazılım-Uygulama (2113)
- Uygulama-Altyapı (955)
- İletişim Ekipmanları (731)
- Bilgisayar Donanımı (434)
- Tüketici Elektroniği (282)
- Elektronik Bileşenler (971)
- Elektronik Ürün ve Bilgisayar Dağıtımı (239)
- Bilimsel ve Teknik Gereçler (347)
- Yarı İletken Ekipman ve Malzemeler (350)
- Yarı İletkenler (611)
- Güneş Enerjisi (222)
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK |
|---|
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Eli Lilly and Company LLY.F | $649.8 710.32 USD |
-3.35
|
$583.51B 637.86B USD | $1.17K 1.27K USD | $620 677.74 USD | $660.2 721.69 USD | $583.51B 637.86B USD | 61.18 | $10.62 11.61 USD | |
| Johnson & Johnson JNJ.BA | $13,475 15.93 USD |
-1.28
|
$391.67T 462.97B USD | $4.78K 5.65 USD | $13,075 15.46 USD | $13,700 16.19 USD | $391.67T 462.97B USD | 10.83 | $1.24K 1.47 USD | |
| Johnson & Johnson JNJ.MX | $3,070 181.78 USD |
-5.68
|
$7.4T 438.07B USD | $2.66K 157.21 USD | $3,070 181.78 USD | $3,085.88 182.72 USD | $7.4T 438.07B USD | 26.56 | $115.55 6.84 USD | |
| Johnson & Johnson JNJB34.SA | $58.51 11.86 USD |
-1.94
|
$2.12T 428.68B USD | $3.08K 624.67 USD | $58 11.76 USD | $59.66 12.09 USD | $2.12T 428.68B USD | 26.96 | $2.17 0.44 USD | |
| AbbVie Inc. ABBV.BA | $24,925 29.46 USD |
-0.2
|
$354.62T 419.18B USD | $741 0.88 USD | $24,025 28.4 USD | $25,400 30.02 USD | $354.62T 419.18B USD | 9.70 | $2.57K 3.03 USD | |
| AbbVie Inc. ABBV.MX | $3,912 231.64 USD |
0
|
$6.92T 409.76B USD | $4 0.24 USD | $3,912 231.64 USD | $3,912 231.64 USD | $6.92T 409.76B USD | 81.96 | $47.73 2.83 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV34.SA | $67.5 13.68 USD |
-0.28
|
$1.91T 387.23B USD | $1.79K 362.2 USD | $65.52 13.28 USD | $67.75 13.73 USD | $1.91T 387.23B USD | 80.35 | $0.84 0.17 USD | |
| Johnson & Johnson JNJ.F | $136.3 148.99 USD |
-3.11
|
$328.46B 359.05B USD | $2.61K 2.85K USD | $133.5 145.93 USD | $139.9 152.93 USD | $328.46B 359.05B USD | 25.96 | $5.25 5.74 USD | |
| Johnson & Johnson JNJ.VI | $135.64 148.27 USD |
-4.34
|
$326.87B 357.32B USD | $980 1.07K USD | $134.82 147.38 USD | $138.9 151.84 USD | $326.87B 357.32B USD | 25.59 | $5.3 5.79 USD | |
| AbbVie Inc. 4AB.F | $169.6 185.4 USD |
-1.95
|
$300.02B 327.96B USD | $2.46K 2.69K USD | $156 170.53 USD | $169.6 185.4 USD | $300.02B 327.96B USD | 78.51 | $2.16 2.36 USD | |
| AbbVie Inc. 4AB.DE | $167.2 182.77 USD |
-5.3
|
$295.77B 323.32B USD | $6.77K 7.4K USD | $156 170.53 USD | $172 188.02 USD | $295.77B 323.32B USD | 77.05 | $2.17 2.37 USD | |
| AbbVie Inc. ABBV.VI | $166.6 182.12 USD |
-5.74
|
$294.71B 322.16B USD | $0 0 USD | $161.6 176.65 USD | $167.4 182.99 USD | $294.71B 322.16B USD | 76.07 | $2.19 2.39 USD | |
| Roche Holding AG ROGN.MX | $6,280.1 371.86 USD |
0
|
$4.87T 288.48B USD | $0 0 USD | $6,280.1 371.86 USD | $6,280.1 371.86 USD | $4.87T 288.48B USD | 26.24 | $239.27 14.17 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| AstraZeneca PLC AZNN.MX | $1,490 88.23 USD |
0
|
$4.62T 273.53B USD | $1 0.06 USD | $1,490 88.23 USD | $1,490 88.23 USD | $4.62T 273.53B USD | 33.22 | $44.85 2.66 USD | |
| AstraZeneca PLC AZN.BA | $44,150 52.19 USD |
-3.5
|
$227.34T 268.73B USD | $1K 1.18 USD | $43,625 51.57 USD | $45,150 53.37 USD | $227.34T 268.73B USD | 9.12 | $4.84K 5.72 USD | |
| Merck & Co., Inc. MRK.BA | $21,975 25.98 USD |
+0.8
|
$222.88T 263.46B USD | $975 1.15 USD | $21,300 25.18 USD | $22,400 26.48 USD | $222.88T 263.46B USD | 0.30 | $72.42K 85.6 USD | |
| Novartis AG NVS.BA | $34,550 40.84 USD |
-2.47
|
$221.64T 261.98B USD | $5 0.01 USD | $34,550 40.84 USD | $34,550 40.84 USD | $221.64T 261.98B USD | 2.73 | $12.61K 14.91 USD | |
| Novartis AG NVSN.MX | $2,235 132.34 USD |
0
|
$4.41T 261.38B USD | $0 0 USD | $2,235 132.34 USD | $2,235 132.34 USD | $4.41T 261.38B USD | 19.08 | $117.11 6.93 USD | |
| Novartis AG N1VS34.SA | $62.73 12.71 USD |
0
|
$1.24T 251.12B USD | $0 0 USD | $62.73 12.71 USD | $62.73 12.71 USD | $1.24T 251.12B USD | 18.95 | $3.31 0.67 USD | |
| Merck & Co., Inc. MRK.MX | $1,672.01 99 USD |
-0.65
|
$4.22T 250.09B USD | $21 1.24 USD | $1,670 98.88 USD | $1,672.01 99 USD | $4.22T 250.09B USD | 12.43 | $134.47 7.96 USD | |
| Roche Holding AG RHHBF | $336.92 — |
+3.67
|
$244.3B — | $50 — | $325 — | $330.5 — | $244.3B — | 28.64 | $11.76 — | |
| Merck & Co., Inc. MRK.SN | $96.42 — |
-25.14
|
$243.56B — | $0 — | $96.42 — | $96.42 — | $243.56B — | 14.30 | $6.74 — | |
| Merck & Co., Inc. MRCK34.SA | $59.46 12.05 USD |
-4.09
|
$1.2T 243.54B USD | $3.02K 611.9 USD | $58.33 11.82 USD | $61.98 12.56 USD | $1.2T 243.54B USD | 12.51 | $4.75 0.96 USD | |
| AstraZeneca PLC A1ZN34.SA | $63.88 12.95 USD |
-4.83
|
$1.19T 240.85B USD | $182 36.89 USD | $63.33 12.84 USD | $65.76 13.33 USD | $1.19T 240.85B USD | 30.27 | $2.11 0.43 USD | |
| Roche Holding AG RHHVF | $294 — |
-3.45
|
$237.83B — | $100 — | $294 — | $294 — | $237.83B — | 25.02 | $11.75 — | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Roche Holding AG RHO6.F | $32.41 35.43 USD |
-6.25
|
$207.4B 226.72B USD | $60 65.59 USD | $32.41 35.43 USD | $32.82 35.87 USD | $207.4B 226.72B USD | 23.83 | $1.36 1.49 USD | |
| AstraZeneca PLC ZEGA.F | $59 64.49 USD |
-4.84
|
$201.03B 219.75B USD | $100 109.31 USD | $59 64.49 USD | $59.5 65.04 USD | $201.03B 219.75B USD | 28.92 | $2.04 2.23 USD | |
| AstraZeneca PLC ZEG.F | $120 131.18 USD |
-5.06
|
$200.55B 219.23B USD | $4.86K 5.31K USD | $118.15 129.15 USD | $121 132.27 USD | $200.55B 219.23B USD | 29.48 | $4.07 4.45 USD | |
| AstraZeneca PLC AZNCF | $127.7 — |
-7.5
|
$215.29B — | $200 — | $127.7 — | $127.7 — | $215.29B — | 28.37 | $4.5 — | |
| Merck & Co., Inc. 6MK.F | $74.1 81 USD |
-0.27
|
$187.18B 204.61B USD | $459 501.75 USD | $72.7 79.47 USD | $74.1 81 USD | $187.18B 204.61B USD | 12.14 | $6.1 6.67 USD | |
| Amgen Inc. AMGN.MX | $6,430 380.73 USD |
0
|
$3.45T 204.53B USD | $0 0 USD | $6,430 380.73 USD | $6,430 380.73 USD | $3.45T 204.53B USD | 42.73 | $150.46 8.91 USD | |
| Merck & Co., Inc. MRK.VI | $73.6 80.45 USD |
-2.77
|
$185.92B 203.23B USD | $1.33K 1.45K USD | $72.4 79.14 USD | $73.9 80.78 USD | $185.92B 203.23B USD | 11.90 | $6.18 6.76 USD | |
| Amgen Inc. AMGN.BA | $13,050 15.43 USD |
-0.19
|
$169.59T 200.46B USD | $405 0.48 USD | $12,750 15.07 USD | $13,225 15.63 USD | $169.59T 200.46B USD | 0.32 | $40.61K 48.01 USD | |
| Novartis AG NOTA.F | $92.2 100.79 USD |
-5.73
|
$182.1B 199.06B USD | $11 12.02 USD | $92 100.57 USD | $92.2 100.79 USD | $182.1B 199.06B USD | 17.33 | $5.32 5.82 USD | |
| Amgen Inc. AMGN34.SA | $60.06 12.17 USD |
-2.88
|
$903.4B 183.11B USD | $1.22K 246.87 USD | $59.85 12.13 USD | $60.06 12.17 USD | $903.4B 183.11B USD | 39.51 | $1.52 0.31 USD | |
| Gilead Sciences, Inc. GILD.BA | $35,700 42.2 USD |
-0.21
|
$143.35T 169.44B USD | $160 0.19 USD | $35,250 41.67 USD | $36,275 42.88 USD | $143.35T 169.44B USD | 87.53 | $407.84 0.48 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,259.6 133.8 USD |
0
|
$2.82T 166.79B USD | $1 0.06 USD | $2,259.6 133.8 USD | $2,259.6 133.8 USD | $2.82T 166.79B USD | 294.21 | $7.68 0.45 USD | |
| Pfizer Inc. PFE.BA | $7,610 9 USD |
-1.04
|
$138.51T 163.72B USD | $12.64K 14.95 USD | $7,340 8.68 USD | $7,800 9.22 USD | $138.51T 163.72B USD | 2.51 | $3.03K 3.58 USD | |
| Gilead Sciences, Inc. GILD34.SA | $311.4 63.12 USD |
-2.3
|
$776.4B 157.36B USD | $73 14.8 USD | $311.4 63.12 USD | $312.05 63.25 USD | $776.4B 157.36B USD | 288.33 | $1.08 0.22 USD | |
| Pfizer Inc. PFE.MX | $465 27.53 USD |
-1.24
|
$2.64T 156.16B USD | $1.29K 76.21 USD | $465 27.53 USD | $470.9 27.88 USD | $2.64T 156.16B USD | 16.54 | $28.11 1.66 USD | |
| Amgen Inc. AMG.DE | $263.35 287.88 USD |
-4.34
|
$141.47B 154.65B USD | $3.98K 4.35K USD | $250 273.28 USD | $268.6 293.62 USD | $141.47B 154.65B USD | 38.44 | $6.85 7.49 USD | |
| Amgen Inc. AMGN.VI | $262.2 286.62 USD |
-4.71
|
$140.86B 153.97B USD | $1.58K 1.73K USD | $251.45 274.87 USD | $269.65 294.76 USD | $140.86B 153.97B USD | 37.83 | $6.93 7.58 USD | |
| Pfizer Inc. PFIZ34.SA | $32.9 6.67 USD |
-2.17
|
$746.36B 151.28B USD | $7.68K 1.56K USD | $32.19 6.52 USD | $33.73 6.84 USD | $746.36B 151.28B USD | 16.61 | $1.98 0.4 USD | |
| Amgen Inc. AMG.F | $255 278.75 USD |
-8.27
|
$136.99B 149.75B USD | $255 278.75 USD | $254 277.66 USD | $255 278.75 USD | $136.99B 149.75B USD | 37.28 | $6.84 7.48 USD | |
| Pfizer Inc. PFE.SN | $26.06 — |
0
|
$147.8B — | $0 — | $26.06 — | $26.06 — | $147.8B — | 18.48 | $1.41 — | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$142.75B — | $0 — | $95.78 — | $95.78 — | $142.75B — | 252.05 | $0.38 — | |
| Bristol-Myers Squibb Company BMY.BA | $24,600 29.08 USD |
-0.3
|
$120.53T 142.47B USD | $2.74K 3.24 USD | $23,925 28.28 USD | $24,600 29.08 USD | $120.53T 142.47B USD | 0 | -$4,737 -5.6 USD | |
| Bristol-Myers Squibb Company BMY.MX | $1,105 65.43 USD |
-2.04
|
$2.25T 133.13B USD | $139 8.23 USD | $1,105 65.43 USD | $1,105 65.43 USD | $2.25T 133.13B USD | 0 | -$87.98 -5.2 USD | |
| Sanofi SNW.F | $93.28 101.97 USD |
-0.24
|
$121.49B 132.8B USD | $2.15K 2.35K USD | $86 94.01 USD | $93.28 101.97 USD | $121.49B 132.8B USD | 21.24 | $4.39 4.8 USD | |
| Sanofi SNYNF | $103.98 — |
-5.34
|
$132.79B — | $100 — | $103.98 — | $103.98 — | $132.79B — | 21.43 | $4.85 — | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Gilead Sciences, Inc. GIS.DE | $96.48 105.47 USD |
-4.87
|
$120.27B 131.48B USD | $16.15K 17.66K USD | $90.73 99.18 USD | $97.85 106.96 USD | $120.27B 131.48B USD | 283.76 | $0.34 0.37 USD | |
| Gilead Sciences, Inc. GIS.F | $96.16 105.12 USD |
-2.87
|
$119.88B 131.04B USD | $1.73K 1.89K USD | $92.31 100.91 USD | $98.08 107.21 USD | $119.88B 131.04B USD | 274.74 | $0.35 0.38 USD | |
| Gilead Sciences, Inc. GILD.VI | $96.06 105.01 USD |
-5.34
|
$119.75B 130.9B USD | $1.18K 1.29K USD | $92.9 101.55 USD | $97.1 106.14 USD | $119.75B 130.9B USD | 274.45 | $0.35 0.38 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $316.18 64.08 USD |
-1.84
|
$643.35B 130.4B USD | $13 2.63 USD | $313.62 63.57 USD | $316.18 64.08 USD | $643.35B 130.4B USD | 0 | -$24.82 -5.03 USD | |
| Sanofi SANO.VI | $93.29 101.98 USD |
-4.53
|
$116.25B 127.08B USD | $826 902.93 USD | $91.21 99.7 USD | $93.77 102.5 USD | $116.25B 127.08B USD | 21.25 | $4.39 4.8 USD | |
| Pfizer Inc. PFE.VI | $20.42 22.32 USD |
-4.22
|
$115.81B 126.6B USD | $7.83K 8.55K USD | $19.9 21.75 USD | $20.6 22.52 USD | $115.81B 126.6B USD | 15.82 | $1.29 1.41 USD | |
| Sanofi SNW2.F | $47 51.38 USD |
-5.24
|
$115.39B 126.14B USD | $100 109.31 USD | $47 51.38 USD | $47 51.38 USD | $115.39B 126.14B USD | 21.36 | $2.2 2.4 USD | |
| Pfizer Inc. PFEB.F | $6.5 7.11 USD |
-5.8
|
$111.13B 121.48B USD | $209 228.47 USD | $6.3 6.89 USD | $6.5 7.11 USD | $111.13B 121.48B USD | 15.11 | $0.43 0.47 USD | |
| GSK plc GSK.BA | $11,725 13.86 USD |
-3.7
|
$95.24T 112.58B USD | $74 0.09 USD | $11,700 13.83 USD | $11,875 14.04 USD | $95.24T 112.58B USD | 26.82 | $437.08 0.52 USD | |
| Bristol-Myers Squibb Company BRM.DE | $49.4 54 USD |
-3.32
|
$100.51B 109.87B USD | $3.84K 4.2K USD | $47.01 51.38 USD | $49.75 54.38 USD | $100.51B 109.87B USD | 0 | -$4 -4.3 USD | |
| Bristol-Myers Squibb Company BRM.F | $49.15 53.72 USD |
-2.53
|
$100B 109.31B USD | $287 313.73 USD | $47.9 52.36 USD | $49.15 53.72 USD | $100B 109.31B USD | 0 | -$3.99 -4.3 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $49.08 53.65 USD |
-3.79
|
$99.86B 109.16B USD | $0 0 USD | $47.64 52.07 USD | $49.52 54.13 USD | $99.86B 109.16B USD | 0 | -$4.05 -4.4 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $811 48.02 USD |
0
|
$1.65T 97.52B USD | $0 0 USD | $811 48.02 USD | $811 48.02 USD | $1.65T 97.52B USD | 25.00 | $32.44 1.92 USD | |
| GSK plc G1SK34.SA | $40.65 8.24 USD |
-5.99
|
$412.74B 83.66B USD | $11 2.23 USD | $40.65 8.24 USD | $42 8.51 USD | $412.74B 83.66B USD | 22.21 | $1.83 0.37 USD | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $39.04 42.68 USD |
-0.81
|
$67.24B 73.5B USD | $30 32.79 USD | $38.06 41.6 USD | $41 44.82 USD | $67.24B 73.5B USD | 26.73 | $1.46 1.6 USD | |
| GSK GLAXF | $17 — |
-15.51
|
$71.82B — | $497 — | $17 — | $17 — | $71.82B — | 20.98 | $0.81 — | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $20.12 21.99 USD |
-9.9
|
$37.75B 41.26B USD | $2K 2.19K USD | $20.12 21.99 USD | $20.12 21.99 USD | $37.75B 41.26B USD | 25.15 | $0.8 0.87 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $43.8 47.88 USD |
-6.41
|
$23.66B 25.87B USD | $420 459.12 USD | $43.8 47.88 USD | $43.8 47.88 USD | $23.66B 25.87B USD | 11.17 | $3.92 4.29 USD | |
| Biogen Inc. BIIB.MX | $2,854 168.99 USD |
0
|
$417.75B 24.74B USD | $0 0 USD | $2,854 168.99 USD | $2,854 168.99 USD | $417.75B 24.74B USD | 12.80 | $222.9 13.2 USD | |
| Biogen Inc. BIIB.BA | $12,400 14.66 USD |
-2.55
|
$18.85T 22.28B USD | $168 0.2 USD | $12,225 14.45 USD | $12,600 14.89 USD | $18.85T 22.28B USD | 1.03 | $12.01K 14.2 USD | |
| Bayer Aktiengesellschaft BAYER.BD | $8,000 22.13 USD |
-2.03
|
$7.86T 21.74B USD | $135 0.37 USD | $7,500 20.74 USD | $8,000 22.13 USD | $7.86T 21.74B USD | 0 | -$1,043.6 -2.8 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $19.87 21.72 USD |
-0.98
|
$19.55B 21.37B USD | $23.4K 25.58K USD | $18.66 20.4 USD | $20.09 21.96 USD | $19.55B 21.37B USD | 0 | -$2.6 -2.8 USD | |
| Bayer Aktiengesellschaft BAYA.F | $4.8 5.25 USD |
-2.04
|
$19.34B 21.14B USD | $1K 1.09K USD | $4.54 4.96 USD | $4.8 5.25 USD | $19.34B 21.14B USD | 0 | -$0.65 -0.7 USD | |
| Biogen Inc. BIIB34.SA | $116.76 23.67 USD |
-4.7
|
$102.96B 20.87B USD | $1 0.2 USD | $116.76 23.67 USD | $116.76 23.67 USD | $102.96B 20.87B USD | 11.17 | $10.45 2.12 USD | |
| Biogen Inc. IDP.DE | $109.1 119.26 USD |
-4.34
|
$15.97B 17.46B USD | $307 335.59 USD | $106.3 116.2 USD | $110.85 121.17 USD | $15.97B 17.46B USD | 10.76 | $10.13 11.07 USD | |
| Biogen Inc. BIIB.VI | $108.4 118.5 USD |
-5.29
|
$15.87B 17.34B USD | $243 265.63 USD | $108.15 118.22 USD | $111.7 122.1 USD | $15.87B 17.34B USD | 10.57 | $10.25 11.2 USD | |
| Biogen Inc. IDP.F | $107 116.97 USD |
-5.93
|
$15.66B 17.12B USD | $20 21.86 USD | $107 116.97 USD | $107 116.97 USD | $15.66B 17.12B USD | 10.57 | $10.12 11.06 USD | |
| Astellas Pharma Inc. YPH.F | $7.75 8.47 USD |
-3.41
|
$14.88B 16.27B USD | $27 29.51 USD | $7.75 8.47 USD | $7.75 8.47 USD | $14.88B 16.27B USD | 0 | -$0.2 -0.2 USD | |
| Astellas Pharma ALPMF | $9 — |
-4.76
|
$16.2B — | $108 — | $9 — | $9 — | $16.2B — | 0 | -$0.22 — | |
| Astellas Pharma Inc. YPHA.F | $7.7 8.42 USD |
-7.78
|
$14.21B 15.53B USD | $0 0 USD | $7.7 8.42 USD | $7.7 8.42 USD | $14.21B 15.53B USD | 0 | -$0.2 -0.2 USD | |
| Cipla Limited CIPLA.BO | $1,384.4 16.75 USD |
-2.2
|
$1.12T 13.53B USD | $127.21K 1.54K USD | $1,310.05 15.85 USD | $1,401.1 16.95 USD | $1.12T 13.53B USD | 22.43 | $61.72 0.75 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $46.64 50.98 USD |
-8.1
|
$9.72B 10.63B USD | $5 5.47 USD | $46.64 50.98 USD | $48.1 52.58 USD | $9.72B 10.63B USD | 23.43 | $1.99 2.18 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $46.64 50.98 USD |
-8.64
|
$9.66B 10.56B USD | $0 0 USD | $46.64 50.98 USD | $47.96 52.43 USD | $9.66B 10.56B USD | 23.43 | $1.99 2.18 USD | |
| Orion Oyj ORINY | $31.1 — |
+0.13
|
$8.18B — | $248 — | $31.06 — | $31.06 — | $8.18B — | 24.29 | $1.28 — | |
| CSPC Pharmaceutical CHJTF | $0.56 — |
-13.85
|
$8.11B — | $11K — | $0.93 — | $0.9499 — | $8.11B — | 11.19 | $0.05 — | |
| Orion Oyj OFK.F | $50.75 55.48 USD |
-1.8
|
$7.27B 7.95B USD | $66 72.15 USD | $50.75 55.48 USD | $50.75 55.48 USD | $7.27B 7.95B USD | 21.59 | $2.35 2.57 USD | |
| Kyowa Kirin KYKOF | $14.75 — |
0
|
$7.89B — | $316 — | $14.75 — | $14.75 — | $7.89B — | 19.40 | $0.76 — | |
| Orion Oyj ORINF | $48.65 — |
+13.09
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
| Kyowa Kirin Co., Ltd. KY4.F | $12.6 13.77 USD |
-3.08
|
$6.92B 7.57B USD | $254 277.66 USD | $12.3 13.45 USD | $12.6 13.77 USD | $6.92B 7.57B USD | 18.00 | $0.7 0.77 USD | |
| Orion Oyj OFK0.F | $24.8 27.11 USD |
-7.46
|
$6.85B 7.49B USD | $0 0 USD | $24.8 27.11 USD | $24.8 27.11 USD | $6.85B 7.49B USD | 21.19 | $1.17 1.28 USD | |
| Abbott India Limited ABBOTINDIA.NS | $28,965.7 350.44 USD |
-0.38
|
$615.5B 7.45B USD | $14.09K 170.42 USD | $27,500.05 332.7 USD | $29,400.05 355.69 USD | $615.5B 7.45B USD | 46.11 | $628.07 7.6 USD | |
| Abbott India Limited ABBOTINDIA.BO | $28,927.9 349.98 USD |
-0.42
|
$614.7B 7.44B USD | $544 6.58 USD | $27,598.55 333.9 USD | $29,299.95 354.48 USD | $614.7B 7.44B USD | 46.10 | $627.46 7.59 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.54 0.59 USD |
-14.63
|
$6.29B 6.87B USD | $1K 1.09K USD | $0.52 0.56 USD | $0.54 0.59 USD | $6.29B 6.87B USD | 10.71 | $0.05 0.05 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $1.85 2.02 USD |
-21.61
|
$5.77B 6.31B USD | $250 273.28 USD | $1.85 2.02 USD | $1.85 2.02 USD | $5.77B 6.31B USD | 10.27 | $0.18 0.2 USD | |
|
Favori hisse senedi yok.
Henüz favori bir hisse senediniz yok, lütfen burada görmek için favorilere ekleyin |
||||||||||
- {{ link.label }} {{link}}